Discovery of N-Trifluoromethylated Noscapines as Novel and Potent Agents for the Treatment of Glioblastoma
- 17 December 2024
- journal article
- research article
- Published by American Chemical Society (ACS) in Journal of Medicinal Chemistry
- Vol. 68 (1) , 247-260
Abstract
The search for new and effective chemotherapeutic agents for the treatment of glioblastoma (GBM) represents an unmet need in drug discovery. Herein, a class of novel N-trifluoromethylated noscapines has been disclosed. Among them, 9'-bromo-N-trifluoromethyl noscapine 15c displayed superior in vitro anti-GBM potency. Unexpectedly, in contrast with the general N-trifluoromethyl amines, these compounds exhibited good hydrolytic stability and further investigation of this distinct stability revealed a novel strategy for the structure modification of tetrahydroisoquinoline alkaloids, where N-methyl could be bioisosterically replaced with trifluoromethyl. Furthermore, 15c showed excellent BBB permeability and good in vivo anti-GBM activity and could efficiently suppress the migration of GBM cells, while no apparent toxicity was observed, thus representing an attractive lead for further drug discovery. Further mechanistic studies revealed that 15c exhibited an ability to induce G2/M-phase arrest in GBM cells associated with the disruption of tubulin polymerization, which is consistent with the mechanism of action of noscapine.Keywords
Funding Information
- Natural Science Foundation of Shanghai Municipality (23ZR1417200)
- National Natural Science Foundation of China (21602060, 21871086, 22171080)
This publication has 44 references indexed in Scilit:
- Reactivity Umpolung of Tertiary Amide Enabled by Catalytic Reductive StannylationAngewandte Chemie International Edition, 2023
- A Novel Class of N‐Sulfonyl and N‐Sulfamoyl Noscapine Derivatives that Promote Mitotic Arrest in Cancer CellsChemMedChem, 2019
- Cellular Interactome Dynamics during Paclitaxel TreatmentCell Reports, 2019
- Direct Synthesis of Thiocarbamoyl Fluorides and Trifluoromethylamines Through Fluorinative DesulfurizationEuropean Journal of Organic Chemistry, 2019
- Noscapine, a Non-addictive Opioid and Microtubule-Inhibitor in Potential Treatment of GlioblastomaNeurochemical Research, 2019
- RETRACTED: Current status and future therapeutic perspectives of glioblastoma multiforme (GBM) therapy: A reviewBiomedicine & Pharmacotherapy, 2017
- MicroRNAs as Multifaceted Players in Glioblastoma Multiforme2017
- Design, synthesis, and evaluation of curcumin-derived arylheptanoids for glioblastoma and neuroblastoma cytotoxicityBioorganic & Medicinal Chemistry Letters, 2013
- Noscapine inhibits tumor growth in TMZ-resistant gliomasCancer Letters, 2011
- Interactions of colchicine with tubulinPharmacology & Therapeutics, 1991